My ePortfolio Register   

4th Metronomic Chemotherapy Meeting /
Continual low-dose metronomic chemotherapy as potentially preferable to aggressive strategies

24th - 25th Jun 2014

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 10.07.14
Views: 3069
Rating:

Prof Yuval Shaked - Israel Institute of Technology, Haifa, Israel

Prof Shaked talks to ecancertv at the Metronomic Chemotherapy Meeting in Milan about the benefits of a metronomic chemotherapy regimen as a less aggressive treatment than high dose chemotherapy, and a more effective maintenance drug, preventing relapse and decreasing metastatic burden.

Previous conferences: highlights



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence